CRNC · Insider Trading
Cerence Inc. Common Stock
Every open-market purchase and sale reported by CRNC officers, directors and 10%+ beneficial owners on SEC Form 4, which must be filed within two business days of the transaction. Sales often reflect scheduled 10b5-1 plans or tax withholding rather than a directional view, so read counts alongside the size and the filer.
| Filed | Insider | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-10-13 | Brian M Krzanich | Chief Executive Officer | Sell | −131,715 | −$1.09M |
| 2026-10-09 | Brian M Krzanich | Chief Executive Officer | Sell | −21,703 | −$173.62K |
| 2026-10-09 | Christian Mentz | EVP, Chief Revenue Officer | Sell | −48,923 | −$391.38K |
| 2026-10-09 | Antonio Rodriquez | CFO | MIXED | −74,614 | −$598.87K |
| 2026-10-09 | Jennifer Salinas | EVP Chief Admin Officer | Sell | −66,153 | −$529.22K |
| 2026-10-09 | Nils Schanz | EVP Product & Technology | Sell | −52,439 | −$419.51K |
| 2026-08-12 | Jennifer Salinas | EVP Chief Admin Officer | Sell | −25,998 | −$229.51K |
| 2026-02-13 | Marcy S Klevorn | Director | A | +12,968 | +$130 |
| 2026-02-13 | Marianne Budnik | Director | A | +12,968 | +$130 |
| 2026-02-13 | Kristi Ann Matus | Director | A | +12,968 | +$130 |
| 2026-02-13 | Douglas Lee Davis | Director | A | +12,968 | +$130 |
| 2026-02-13 | Marion Harris | Director | A | +12,968 | +$130 |
| 2026-01-12 | Christian Mentz | EVP, Chief Revenue Officer | A | +131,694 | +$1.63M |
| 2026-01-12 | Brian M Krzanich | Chief Executive Officer | A | +263,338 | +$3.25M |
| 2026-01-12 | Nils Schanz | EVP Product & Technology | A | +87,796 | +$1.08M |
| 2026-01-12 | Jennifer Salinas | EVP Chief Admin Officer | A | +131,694 | +$1.63M |
| 2026-01-12 | Antonio Rodriquez | CFO | A | +131,694 | +$1.63M |
| 2025-11-24 | Antonio Rodriquez | CFO | A | +166,821 | +$1.73M |
| 2025-11-24 | Brian M Krzanich | Chief Executive Officer | A | +552,766 | +$5.72M |
| 2025-11-24 | Jennifer Salinas | EVP Chief Admin Officer | A | +242,044 | +$2.51M |
| 2025-11-24 | Nils Schanz | EVP Product & Technology | A | +49,905 | +$516.52K |
| 2025-11-24 | Christian Mentz | EVP, Chief Revenue Officer | A | +49,905 | +$516.52K |
| 2025-10-10 | Brian M Krzanich | Chief Executive Officer | Sell | −132,075 | −$1.51M |
| 2025-10-07 | Nils Schanz | EVP Product & Technology | Sell | −30,560 | −$389.86K |
| 2025-10-07 | Antonio Rodriquez | CFO | MIXED | −36,552 | −$471.15K |
| 2025-10-07 | Jennifer Salinas | EVP Chief Admin Officer | Sell | −142,778 | −$1.79M |
| 2025-10-07 | Christian Mentz | EVP, Chief Revenue Officer | Sell | −26,872 | −$342.81K |
| 2025-10-03 | Nils Schanz | EVP Product & Technology | A | +90,252 | +$903 |
| 2025-08-18 | Christian Mentz | EVP, Chief Revenue Officer | Sell | −4,000 | −$50.94K |
| 2025-04-02 | Marion Harris | Director | A | +14,210 | +$142 |
| 2025-02-25 | Christian Mentz | EVP, Chief Revenue Officer | Sell | −3,600 | −$53.03K |
| 2025-02-18 | Kristi Ann Matus | Director | A | +9,955 | +$100 |
| 2025-02-18 | Alfred A Nietzel | Director | A | +9,955 | +$100 |
| 2025-02-18 | Douglas Lee Davis | Director | A | +9,955 | +$100 |
| 2025-02-18 | Arun Sarin | Director | A | +9,955 | +$100 |
| 2025-02-18 | Marcy S Klevorn | Director | A | +9,955 | +$100 |
| 2025-02-18 | Marianne Budnik | Director | A | +9,955 | +$100 |
| 2025-02-04 | Thomas L Beaudoin | Director | Sell | −5,000 | −$58.40K |
| 2025-01-15 | Nils Schanz | EVP Product & Technology | A | +93,720 | +$1.29M |
| 2025-01-15 | Christian Mentz | EVP, Chief Revenue Officer | A | +93,720 | +$1.29M |
| 2025-01-02 | Thomas L Beaudoin | Director | Sell | −5,000 | −$39.90K |
| 2024-12-10 | Antonio Rodriquez | CFO | A | +313,283 | +$2.60M |
| 2024-12-03 | Thomas L Beaudoin | Director | Sell | −5,000 | −$36.80K |
| 2024-11-26 | Katherine Roman | VP Corporate Controller | Sell | −635 | −$4.58K |
| 2024-11-26 | Jennifer Salinas | EVP Chief Admin Officer | Sell | −37,356 | −$254.01K |
| 2024-11-26 | Thomas L Beaudoin | Director | Sell | −12,088 | −$87.15K |
| 2024-11-04 | Thomas L Beaudoin | Director | Sell | −5,000 | −$15.55K |
| 2024-10-15 | Brian M Krzanich | Chief Executive Officer | A | +1,038,062 | +$10.38K |
| 2024-10-09 | Nils Schanz | EVP Product & Technology | Sell | −32,259 | −$104.72K |
| 2024-10-09 | Thomas L Beaudoin | Director | Sell | −11,403 | −$32.95K |
| Insider | Role | Shares Held | Value |
|---|---|---|---|
| Brian M Krzanich | Chief Executive Officer | 1,568,673 | $12.93M |
| Jennifer Salinas | EVP Chief Admin Officer | 627,876 | $5.17M |
| Antonio Rodriquez | CFO | 500,632 | $4.13M |
| Nils Schanz | EVP Product & Technology | 290,243 | $2.39M |
| Christian Mentz | EVP, Chief Revenue Officer | 244,551 | $2.02M |
| Thomas L Beaudoin | Director | 173,966 | $1.43M |
| Arun Sarin | Director | 63,485 | $523.12K |
| Marianne Budnik | Director | 60,166 | $495.77K |
| Kristi Ann Matus | Director | 54,737 | $451.03K |
| Alfred A Nietzel | Director | 42,198 | $347.71K |
| Douglas Lee Davis | Director | 39,544 | $325.84K |
| Katherine Roman | VP Corporate Controller | 37,330 | $307.60K |
| Marcy S Klevorn | Director | 35,404 | $291.73K |
| Marion Harris | Director | 27,178 | $223.95K |
Form 4 reports a change in beneficial ownership by an officer, director or 10%+ holder, and must be filed within two business days of the transaction — so this is close to real time, unlike the 45-day-lagged 13F institutional data.
Transaction codes matter more than the raw buy/sell count. Code P is an open-market purchase — an insider choosing to buy with their own money, which is the signal most research treats as informative. Code S is a sale, but sales are frequently pre-scheduled under a 10b5-1 plan or cover tax withholding on vesting equity, so a run of sales often says nothing directional. Codes A and M are grants and option exercises rather than open-market decisions.
Full filing history and per-insider positions are on the CRNC quote page; the site-wide leaderboard is on the insider transactions hub.
Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.